Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1993 Jan;91(1):344-9.
doi: 10.1172/JCI116191.

Tissue distribution of beta 3-adrenergic receptor mRNA in man

Affiliations
Comparative Study

Tissue distribution of beta 3-adrenergic receptor mRNA in man

S Krief et al. J Clin Invest. 1993 Jan.

Abstract

Expression of mRNA for beta 1-, beta 2-, and beta 3-adrenergic receptors (beta 1-, beta 2-, and beta 3-AR) was investigated in human tissues. beta 1- and beta 2-AR mRNA distribution correlated with that of the cognate receptors established by pharmacological studies. beta 3-AR transcripts were abundant in infant perirenal brown adipose tissue, characterized by the presence of uncoupling protein (UCP) mRNA. In adult whole adipose tissues, beta 3-AR mRNA levels were high in deep deposits such as perirenal and omental, and lower in subcutaneous. In these deposits, UCP mRNA levels paralleled those of beta 3-AR. However, isolated omental and subcutaneous adipose cells, enriched in white adipocytes, expressed beta 3-AR but no UCP transcripts. beta 3-AR mRNA was highly expressed in gallbladder, and to a much lower extent in colon, independently of UCP mRNA. Quadriceps or abdominal muscles, heart, liver, lung, kidney, thyroid, and lymphocytes did not express intrinsic beta 3-AR mRNA. This study demonstrates that substantial amounts of brown adipocytes exist throughout life in adipose deposits, which are generally classified as white. These deposits are the main sites of beta 3-AR expression, which also occurs in gallbladder and colon. beta 3-AR may thus be involved in the control of lipid metabolism, possibly from fat assimilation in the digestive tract, to triglyceride storage and mobilization in adipose tissues.

PubMed Disclaimer

References

    1. Trends Pharmacol Sci. 1990 Jan;11(1):3-7 - PubMed
    1. Trends Pharmacol Sci. 1989 Aug;10(8):316-20 - PubMed
    1. Br J Pharmacol. 1990 Aug;100(4):831-9 - PubMed
    1. Br J Pharmacol. 1990 Nov;101(3):569-74 - PubMed
    1. Eur J Biochem. 1991 Mar 14;196(2):357-61 - PubMed

Publication types

MeSH terms

Substances